8 June 2017 - Deborah Wilkes
Archived
Valeant Pharmaceuticals International is selling its iNova Pharmaceuticals business to two private-equity firms for USD930 million in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.